156 related articles for article (PubMed ID: 10073602)
21. Cutis laxa for diagnosis of γ1-heavy-chain deposition disease: Report of four cases.
Chavarot N; Battistella M; Vignon M; Baron M; Girerd S; Jachiet M; Asli B; Galicier L; Malphettes M
J Dermatol; 2018 Oct; 45(10):1211-1215. PubMed ID: 30035313
[TBL] [Abstract][Full Text] [Related]
22. IgG heavy-chain deposition disease.
Katz A; Zent R; Bargman JM
Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
[TBL] [Abstract][Full Text] [Related]
23. Heavy chain deposition disease: an overview.
Oe Y; Soma J; Sato H; Ito S
Clin Exp Nephrol; 2013 Dec; 17(6):771-8. PubMed ID: 23652830
[TBL] [Abstract][Full Text] [Related]
24. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease.
Soma J; Tsuchiya Y; Sakuma T; Sato H
Clin Nephrol; 2008 May; 69(5):383-6. PubMed ID: 18538103
[TBL] [Abstract][Full Text] [Related]
25. Metachronous development of nonamyloidogenic [lambda] light chain deposition disease and IgG heavy chain amyloidosis in the same patient.
Copeland JN; Kouides PA; Grieff M; Nadasdy T
Am J Surg Pathol; 2003 Nov; 27(11):1477-82. PubMed ID: 14576484
[TBL] [Abstract][Full Text] [Related]
26. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.
Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR
Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817
[TBL] [Abstract][Full Text] [Related]
28. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
[TBL] [Abstract][Full Text] [Related]
29. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy.
Nakatsuka A; Maeshima Y; Sarai A; Yanai H; Sugiyama H; Yamasaki Y; Makino H
Clin Nephrol; 2005 Sep; 64(3):221-7. PubMed ID: 16175947
[TBL] [Abstract][Full Text] [Related]
30. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
31. Light and heavy chain deposition disease associated with CH1 deletion.
Cohen C; El-Karoui K; Alyanakian MA; Noel LH; Bridoux F; Knebelmann B
Clin Kidney J; 2015 Apr; 8(2):237-9. PubMed ID: 25815184
[TBL] [Abstract][Full Text] [Related]
32. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
Buxbaum J; Gallo G
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
[TBL] [Abstract][Full Text] [Related]
33. Complete variable region deletion in a mu heavy chain disease protein (ROUL). Correlation with light chain secretion.
Cogné M; Aucouturier P; Brizard A; Dreyfus B; Duarte F; Preud'homme JL
Leuk Res; 1993 Jun; 17(6):527-32. PubMed ID: 8505850
[TBL] [Abstract][Full Text] [Related]
34. Nodular glomerulosclerosis associated with multiple myeloma. Role of light chain isoelectric point.
Palant CE; Bonitati J; Bartholomew WR; Brentjens JR; Walshe JJ; Bentzel CJ
Am J Med; 1986 Jan; 80(1):98-102. PubMed ID: 3079952
[TBL] [Abstract][Full Text] [Related]
35. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal immunoglobulin light and heavy chain deposition diseases: molecular models of common renal diseases.
Ronco P; Plaisier E; Aucouturier P
Contrib Nephrol; 2011; 169():221-231. PubMed ID: 21252522
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.
Preud'Homme JL; Morel-Maroger L; Brouet JC; Mihaesco E; Mery JP; Seligmann M
Clin Exp Immunol; 1980 Dec; 42(3):545-53. PubMed ID: 6783355
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin heavy chain gene rearrangement in heavy chain deposition disease suggests it is a plasma cell disease: a case report.
Rao Q; Xu R; Wan Q
J Int Med Res; 2022 Mar; 50(3):3000605221086428. PubMed ID: 35301906
[TBL] [Abstract][Full Text] [Related]
39. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
[TBL] [Abstract][Full Text] [Related]
40. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease.
Buxbaum JN
Amyloid; 2001 Jun; 8(2):84-93. PubMed ID: 11409038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
